COMPASS THERAPEUTICS, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
COMPASS THERAPEUTICS, INC. (CMPX) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $36.02 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $36.02M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $55.74M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $31.21M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $46.78M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations as first filed |
|---|---|---|
| 2026-06-30 | $36.02M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $55.74M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $31.21M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $46.78M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $23.42M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $41.62M 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $44.05M 10-Q · filed 2026-08-06 | $43.48M 10-K · filed 2025-02-27 |
| 2024-09-30 | $37.37M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $19.40M 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $23.99M 10-Q · filed 2025-05-08 | $23.67M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $24.23M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $30.43M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $19.28M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $27.03M 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $34.95M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $16.48M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $26.24M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $136.38M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $144.51M 10-K · filed 2024-03-21 | |
| 2021-09-30 | $25.72M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $31.42M 10-Q · filed 2021-08-16 | |
| 2021-06-20 | $31.42M 10-Q · filed 2022-08-01 | |
| 2021-03-31 | $39.85M 10-Q · filed 2022-05-09 | |
| 2020-12-31 | $47.34M 10-K · filed 2023-03-15 | |
| 2020-09-30 | $55.78M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $65.63M 10-Q · filed 2021-08-16 | |
| 2020-03-31 | $17.79M 10-Q · filed 2021-04-30 | |
| 2019-12-31 | $25.57M 10-K · filed 2022-03-18 | |
| 2019-09-30 | $31.34M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $38.07M 10-Q · filed 2020-08-13 | |
| 2018-12-31 | $57.77M 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |